Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-08-22 00:00:00 ET · period of report 2025-08-21 · accession 0001562180-25-005953 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-08-22 | 2025-08-21 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $308.75 | -11.0K | 43.1K | -20% | -$3.40M |
| DT | 2025-08-22 | 2025-08-21 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DT | 2025-08-22 | 2025-08-21 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -11.0K | 77.0K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-21 | S | D | 4,234 | $309.43 | 38,876 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $308.86 to $309.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-08-21 | S | D | 2,095 | $310.25 | 36,781 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $309.86 to $310.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-08-21 | M | A | 11,000 | $135.42 | 47,781 | D | — | — | |
| 4 | Common | Common Stock | 2025-08-21 | S | D | 600 | $304.57 | 47,181 | D | — | — | |
| 5 | Common | Common Stock | 2025-08-21 | S | D | 300 | $306.12 | 46,881 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $305.63 to $306.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2025-08-21 | S | D | 1,441 | $307.39 | 45,440 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $306.85 to $307.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2025-08-21 | S | D | 2,330 | $308.43 | 43,110 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $307.85 to $308.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Derivative | Stock Option | 2025-08-21 | M | D | 11,000 | $0.00 | 77,000 | D | $135.42 · 2023-03-15 to 2027-03-15 | 11,000 Common Stock |